Acc. 023/2017 August 10, 2017 To: The President The Stock Exchange of Thailand Dear Sir, Subject: Management Discussion and Analysis Quarter 2 Ending 30 Jun 2017 S. Khonkaen Foods Public Company

, or 5.4% increased from Q1/2018 in Baht 35.7 million of which Baht 688.3 million was revenue from sales. The Company had successfully recorded a sales growth of Baht 51.7 million, or 8.1% year-over-year

690.7 million, or 4.9 % increased from Q3/2016 in Baht 32.2 million of which Baht 676.3 million were revenue from sales. The company had successfully recorded a sales growth of Baht 25.7 million, or 3.9

2.8 % increased from year 2016 in Baht 76.5 million of which Baht 2,707.5 million were revenue from sales. The company had successfully recorded a sales growth of Baht 67.9 million, or 2.6 %. Please

will meet the demand of the customers, which will increase Company’s competitiveness and continuously maintain growth rate of the Company. (9) Source of Funds : The Subsidiary will use its term loans and

revenue growth. DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 As of June

security revenue , the Company posted 20% growth in 3Q17 which was attributable to the increase of number of patients and bill amount. Cost of Hospital Operations Cost of hospital operations during 9M17

”) increased by 21% yoy and 27% yoy, respectively. In light of non-social security revenue, the Company posted 13% growth in 2017 and 8% in 4Q17 which was attributable to the increase of number of patients and

ออกและเสนอขายโดยบริษัทที่กำลับเติบโต (Growth Company) และบริษัทที่มีฐานะทางการเงินดี มีผลกำไร และจ่ายเงินปันผลอย่างสม่ำเสมอ (Value Company) ซึ่งกลยุทธ์นี้ต้องการทำกำไรส่วนเกินทุน และรับรายได้ประจำจาก

details are as follows; Operating Performance 1. Revenues Unit: Million Baht In the overview of Revenue from sale – net for the 1st quarter 2019, the Company could generate growth rate from the revenue of